Atul C. Pande

3.0k total citations
36 papers, 2.1k citations indexed

About

Atul C. Pande is a scholar working on Experimental and Cognitive Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Atul C. Pande has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Experimental and Cognitive Psychology, 14 papers in Psychiatry and Mental health and 10 papers in Pharmacology. Recurrent topics in Atul C. Pande's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (14 papers), Treatment of Major Depression (10 papers) and Electroconvulsive Therapy Studies (7 papers). Atul C. Pande is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (14 papers), Treatment of Major Depression (10 papers) and Electroconvulsive Therapy Studies (7 papers). Atul C. Pande collaborates with scholars based in United States, Canada and United Kingdom. Atul C. Pande's co-authors include Douglas E. Feltner, Jerri G. Crockatt, Carol A. Janney, Mark H. Pollack, R. Bruce Lydiard, Gwen L. Zornberg, Martha Greiner, John L. Werth, Maria Liu-Dumaw and Robert J. Bielski and has published in prestigious journals such as Neuron, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Atul C. Pande

35 papers receiving 2.0k citations

Peers

Countries citing papers authored by Atul C. Pande

Since Specialization

Citations

This map shows the geographic impact of Atul C. Pande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul C. Pande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul C. Pande more than expected).

Fields of papers citing papers by Atul C. Pande

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atul C. Pande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul C. Pande. The network helps show where Atul C. Pande may publish in the future.

Co-authorship network of co-authors of Atul C. Pande

This figure shows the co-authorship network connecting the top 25 collaborators of Atul C. Pande. A scholar is included among the top collaborators of Atul C. Pande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atul C. Pande. Atul C. Pande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS Drugs 2014 ·Neuron ·Dennis W. Choi, (unknown), Linda S. Brady, Timothy Coetzee, William W. Fisher, Steven E. Hyman, Atul C. Pande, Steven M. Paul, William Z. Potter, Benjamin N. Roin, Todd Sherer	51
2	Long-term efficacy of pregabalin in generalized anxiety disorder 2008 ·International Clinical Psychopharmacology ·Douglas E. Feltner, Hans‐Ulrich Wïttchen, Richard J. Kavoussi, (unknown), F. Baldinetti, Atul C. Pande	83
3	Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety Disorder 2006 ·The Journal of Clinical Psychiatry ·Stuart Montgomery, (unknown), Gwen L. Zornberg, Siegfried Kasper, Atul C. Pande	145
4	Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder 2005 ·Journal of Clinical Psychopharmacology ·Robert Pohl, Douglas E. Feltner, Ronald R. Fieve, Atul C. Pande	129
5	Efficacy of the Novel Anxiolytic Pregabalin in Social Anxiety Disorder 2004 ·Journal of Clinical Psychopharmacology ·Atul C. Pande, Douglas E. Feltner, James W. Jefferson, Jonathan Davidson, Mark H. Pollack, Murray B. Stein, R. Bruce Lydiard, (unknown), Paula D. Robinson, M Słomkowski, E. DuBoff, (unknown), Carol A. Janney, John L. Werth	131
6	Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial 2003 ·American Journal of Psychiatry ·Atul C. Pande, Jerri G. Crockatt, Douglas E. Feltner, Carol A. Janney, Ward T. Smith, Richard H. Weisler, Peter D. Londborg, Robert J. Bielski, Dan Zimbroff, Jonathan Davidson, Maria Liu-Dumaw	244
7	Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder 2000 ·Journal of Clinical Psychopharmacology ·Atul C. Pande, Mark H. Pollack, Jerri G. Crockatt, Martha Greiner, Guy Chouinard, R. Bruce Lydiard, C. Barr Taylor, Stephen R. Dager, Thomas Shiovitz	212
8	Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1 2000 ·Bipolar Disorders ·Atul C. Pande, Jerri G. Crockatt, Carol A. Janney, John L. Werth, (unknown), (unknown)	227
9	Effects of the CCKB antagonist CI-988 on responses to mCPP in generalized anxiety disorder 1999 ·Psychiatry Research ·Andrew W. Goddard, Scott W. Woods, Roy Money, Atul C. Pande, Dennis S. Charney, Wayne K. Goodman, George R. Heninger, Lawrence H. Price	11
10	Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder 1999 ·Biological Psychiatry ·Atul C. Pande, Martha Greiner, (unknown), R. Bruce Lydiard, Mark Pierce	38
11	The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients 1997 ·Psychopharmacology ·Harold J.G.M. van Megen, H.G.M. Westenberg, Johan A. den Boer, (unknown), (unknown), Atul C. Pande	57
12	Polysomnographic studies in patients referred for ECT: pre-ECT studies. 1996 ·PubMed ·Leon Grunhaus, James E. Shipley, Alan S. Eiser, Atul C. Pande, Rajiv Tandon, Anna L. Remen, John F. Greden	7
13	A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder 1995 ·Journal of Clinical Psychopharmacology ·(unknown), Robert E. Pyke, (unknown), Neal R. Cutler, Edward E. Schweizer, Charles S. Wilcox, (unknown), Martha Greiner, Mark Pierce, Atul C. Pande	63
14	Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients 1994 ·Psychiatry Research ·John H. Heiligenstein, Douglas E. Faries, A. John Rush, John Sahl Andersen, Atul C. Pande, Howard P. Roffwarg, David L. Dünner, J. Christian Gillin, Steven James, Henry W. Lahmeyer, John Zajecka, Gary D. Tollefson, (unknown)	24
15	Sleep Electroencephalographic Studies After ECT: Age and Clinical Response 1994 ·American Journal of Geriatric Psychiatry ·Leon Grunhaus, James E. Shipley, Alan S. Eiser, Anna L. Remen, Atul C. Pande, Rajiv Tandon, John F. Greden	3
16	Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic 1993 ·Biological Psychiatry ·Sally K. Guthrie, Leon Grunhaus, Atul C. Pande, M. Hariharan	6
17	A preliminary magnetic resonance imaging study of ECT-treated depressed patients 1990 ·Biological Psychiatry ·Atul C. Pande, Leon Grunhaus, Alex M. Aisen, Roger F. Haskett	19
18	Electroconvulsive therapy in delusional and non-delusional depressive disorder 1990 ·Journal of Affective Disorders ·Atul C. Pande, Leon Grunhaus, Roger F. Haskett, John F. Greden	12
19	Major Depressive Disorder and Panic Disorder Effects of Comorbidity on Treatment Outcome with Antidepressant Medications 1988 ·Clinical Neuropharmacology ·Leon Grunhaus, (unknown), (unknown), Atul C. Pande, Roger F. Haskett	47
20	Monitoring of antidepressant response to ECT with polysomnographic recordings and the dexamethasone suppression test 1988 ·Psychiatry Research ·Leon Grunhaus, (unknown), Atul C. Pande, Alan S. Eiser, Roger F. Haskett, John F. Greden, James E. Shipley	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact